These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12690622)

  • 1. Irinotecan hydrochloride.
    Wilkinson K
    Clin J Oncol Nurs; 2001; 5(4):179-80, 184. PubMed ID: 12690622
    [No Abstract]   [Full Text] [Related]  

  • 2. Irinotecan hydrochloride: drug profile and nursing implications of a topoisomerase I inhibitor in patients with advanced colorectal cancer.
    Berg D
    Oncol Nurs Forum; 1998 Apr; 25(3):535-43. PubMed ID: 9568608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced or recurrent colorectal cancer with irinotecan in Japan and elsewhere.
    Sato T; Hatate K; Ikeda A; Yamanashi T; Ozawa H; Onosato W; Nakamura T; Ihara A; Watanabe M
    Expert Opin Pharmacother; 2008 May; 9(7):1223-8. PubMed ID: 18422478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Irinotecan in colorectal cancer].
    Pozzo C; Cassano A; Barone C
    Tumori; 2001; 87(1 Suppl 1):S49-50. PubMed ID: 11300023
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves irinotecan as first-line therapy for colorectal cancer.
    Oncology (Williston Park); 2000 May; 14(5):652, 654. PubMed ID: 10853457
    [No Abstract]   [Full Text] [Related]  

  • 6. Topoisomerase I inhibitors: topotecan and irenotecan.
    Creemers GJ; Lund B; Verweij J
    Cancer Treat Rev; 1994 Jan; 20(1):73-96. PubMed ID: 8293429
    [No Abstract]   [Full Text] [Related]  

  • 7. CPT-11 (irinotecan) in the treatment of colorectal cancer: a new mechanism of action for additional activity.
    Bleiberg H
    Tumori; 1997; 83(1 Suppl):S85-6. PubMed ID: 9154078
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies for success: optimizing oral therapies in breast and colorectal cancer.
    Davies MJ
    ONS News; 2006; 21(8 Suppl):7-8. PubMed ID: 16925129
    [No Abstract]   [Full Text] [Related]  

  • 9. [Irinotecan: various administration schedules, study of drug combinations, phase I experience].
    Boige V; Raymond E; Armand JP
    Bull Cancer; 1998 Dec; Spec No():26-32. PubMed ID: 9932081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic approach for colorectal cancer with topoisomerase as a molecular target].
    Tsunoda T
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():472-5. PubMed ID: 14574938
    [No Abstract]   [Full Text] [Related]  

  • 11. [CPT-11: new drug for metastatic colorectal cancer].
    Barone C; Pozzo C; Cassano A
    Tumori; 1999; 85(6):A1-11. PubMed ID: 10774581
    [No Abstract]   [Full Text] [Related]  

  • 12. Irinotecan for colorectal cancer: a small step forward.
    O'Connell MJ
    Lancet; 1998 Oct; 352(9138):1402. PubMed ID: 9807982
    [No Abstract]   [Full Text] [Related]  

  • 13. [Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
    Terauchi F
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():175-8. PubMed ID: 15535228
    [No Abstract]   [Full Text] [Related]  

  • 14. Colorectal cancer chemotherapy: irinotecan.
    Rougier P; Mitry E
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):138-43. PubMed ID: 11049046
    [No Abstract]   [Full Text] [Related]  

  • 15. [Irinotecan (CPT-11) therapy for advanced gastric cancer].
    Sakata Y
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():386-92. PubMed ID: 11424411
    [No Abstract]   [Full Text] [Related]  

  • 16. Irinotecan and other agents in upper gastrointestinal and colorectal carcinomas. The University of Texas M. D. Anderson Cancer Center Investigators' Workshop, Volume 3. Introduction.
    Ajani JA
    Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):10-2. PubMed ID: 14569840
    [No Abstract]   [Full Text] [Related]  

  • 17. Irinotecan for the treatment of cervical cancer.
    Verschraegen CF
    Oncology (Williston Park); 2002 May; 16(5 Suppl 5):32-4. PubMed ID: 12109804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camptothecins: new enthusiasm for an old drug.
    Rowe PM
    Lancet; 1996 Mar; 347(9005):892. PubMed ID: 8622402
    [No Abstract]   [Full Text] [Related]  

  • 19. Moving ahead: challenges with combination therapies for colorectal cancer.
    ONS News; 2004; 19(9 Suppl):13-4. PubMed ID: 15478568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinotecan in the treatment of colorectal cancer.
    Fuchs C; Mitchell EP; Hoff PM
    Cancer Treat Rev; 2006 Nov; 32(7):491-503. PubMed ID: 16959432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.